REGENERON PHARMACEUTICALS INC·4

Dec 13, 4:52 PM ET

Terifay Robert J 4

4 · REGENERON PHARMACEUTICALS INC · Filed Dec 13, 2017

Insider Transaction Report

Form 4
Period: 2017-12-12
Terifay Robert J
SVP Commercial
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2017-12-12+32,30032,300 total
    Exercise: $378.98Exp: 2027-12-12Common Stock (32,300 underlying)
Footnotes (1)
  • [F1]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT